FdaApplication

BLA 761452

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAccord BioPharma Inc.
application_typeBLA
approval_date2026-05-15

Products (3)

ProductActive ingredientStrengthDosage form
IMMGOLISGOLIMUMAB-SLDI100MG/MLInjection
IMMGOLISGOLIMUMAB-SLDI50MG/0.5ML (100MG/ML)Injection
IMMGOLIS INTRIGOLIMUMAB-SLDI50MG/4ML (12.5MG/ML)Injection

3 products